EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+17.32%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$481M
AUM Growth
+$50.2M
(+12%)
Cap. Flow
+$58.7M
Cap. Flow
% of AUM
12.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
EyePoint Pharmaceuticals
EYPT
|
+$58.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
EyePoint Pharmaceuticals
EYPT
$944M
| $150M | 31.11% |
4,190,396
+1,643,357
| +65% | +$58.7M |
|
2
Axogen
AXGN
$755M
| $137M | 28.44% |
3,711,111
| – | – |
|
|
CORI
3
DELISTED
Corium International, Inc.
CORI
| $89M | 18.5% |
9,353,304
| – | – |
|
|
RVNC
4
DELISTED
Revance Therapeutics, Inc.
RVNC
| $83.1M | 17.27% |
3,342,047
| – | – |
|
5
MediciNova
MNOV
$59.8M
| $14.6M | 3.04% |
1,170,370
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $6.68M | 1.39% |
125,747
| – | – |
|
7
Gyre Therapeutics
GYRE
$706M
| $861K | 0.18% |
10,483
| – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $372K | 0.08% |
1,956,397
| – | – |
|